[1]
B. F. Zuberi, “Quality and Efficacy Concerns with Generics in Treatment of Hepatitis C with Directly Acting Antivirals”, J Dow Univ Health Sci, vol. 11, no. 2, pp. 29–30, Aug. 2017.